sindaxel 6 mg/ml (30 mg/5 ml, 100 mg/16,67 ml, 260 mg/43,33 ml, 300 mg/50 ml) koncentrat do sporządzania roztworu do infuzji
actavis group ptc ehf. - paclitaxelum - koncentrat do sporządzania roztworu do infuzji - 6 mg/ml (30 mg/5 ml, 100 mg/16,67 ml, 260 mg/43,33 ml, 300 mg/50 ml)
paclitaxel-ebewe 6 mg/ml koncentrat do sporządzania roztworu do infuzji
ebewe pharma ges.m.b.h nfg. kg - paclitaxelum - koncentrat do sporządzania roztworu do infuzji - 6 mg/ml
paclitaxelum accord 6 mg/ml koncentrat do sporządzania roztworu do infuzji
accord healthcare polska sp. z o.o. - paclitaxelum - koncentrat do sporządzania roztworu do infuzji - 6 mg/ml
tranexamic acid accord 100 mg/ml roztwór do wstrzykiwań
accord healthcare polska sp. z o.o. - acidum tranexamicum - roztwór do wstrzykiwań - 100 mg/ml
paclitaxel kabi 6 mg/ml koncentrat do sporządzania roztworu do infuzji
fresenius kabi polska sp. z o.o. - paclitaxelum - koncentrat do sporządzania roztworu do infuzji - 6 mg/ml
kymriah
novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - inne środki przeciwnowotworowe - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.
tecvayli
janssen-cilag international n.v. - teclistamab - szpiczak mnogi - Środki przeciwnowotworowe - tecvayli is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.